Skip to main content
. Author manuscript; available in PMC: 2023 Apr 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 Jan 3;111(4):896–908. doi: 10.1002/cpt.2506

Figure 1: Individual estimated clearance by CYP3A5 metabolizer status.

Figure 1:

Clearance is summarized for normal, intermediate, and poor metabolizers. The hinge is set at the median, the boxes span the 25th to 75th percentile, and the whiskers extend to the most extreme datum which is at most 1.5 times the interquartile range. Clearances are shown for (A) the entire cohort and (B) separately for individuals whose self-reported race was Black vs. the rest of the cohort.